Pacer Advisors
VERA icon

Pacer Advisors’s Vera Therapeutics VERA Stock Holding History

Pacer Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53K Buy
+1,227
New +$45.7K ﹤0.01% 2026
2024
Q3 		– Sell
-693
Closed -$25.1K – 2704
2024
Q2 		$25.1K Sell
693
-117
-14% -$4.64K ﹤0.01% 3385
2024
Q1 		$34.9K Buy
+810
New +$28.9K ﹤0.01% 3310

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pacer Advisors's VERA Position: Q2 2026 in Review

Pacer Advisors opened a new position in Vera Therapeutics (VERA) in Q2 2026: 1,227 shares worth $53K. The stake represents ﹤0.01% of the portfolio and ranks #2026 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in VERA as recently as Q2 2024.

Pacer Advisors first reported a position in VERA in Q1 2024 and has held it in 3 quarters since. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Pacer Advisors held 1,227 shares of Vera Therapeutics worth $53K as of Q2 2026.
  • Vera Therapeutics was a new Pacer Advisors position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2026 holding.
  • Pacer Advisors first reported a position in Vera Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.